VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ITGRInteger Holdings Corporation
$90.96$3.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ITGR logoInteger Holdings Corporation(ITGR)Earnings, Financials & Key Ratios

ITGR•NYSE
31.5× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDevice suppliers, distribution, and services
AboutInteger Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.Show more
  • Revenue$1.85B+7.6%
  • EBITDA$335M+5.4%
  • Net Income$103M-14.3%
  • EPS (Diluted)2.89-15.0%
  • Gross Margin23.06%-14.2%
  • EBITDA Margin18.15%-2.0%
  • Operating Margin11.33%-6.6%
  • Net Margin5.57%-20.3%
  • ROE6.11%-20.1%

ITGR Key Insights

Integer Holdings Corporation (ITGR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 11.5%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ITGR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ITGR Price & Volume

Integer Holdings Corporation (ITGR) stock price & volume — 10-year historical chart

Loading chart...

ITGR Growth Metrics

Integer Holdings Corporation (ITGR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.72%
5 Years11.46%
3 Years11.52%
TTM6.01%

Profit CAGR

10 Years-
5 Years5.87%
3 Years15.68%
TTM84.5%

EPS CAGR

10 Years-
5 Years4.4%
3 Years13.82%
TTM90.05%

Return on Capital

10 Years5.84%
5 Years6.19%
3 Years6.86%
Last Year6.94%

ITGR Recent Earnings

Integer Holdings Corporation (ITGR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026
Metric
Actual
Est
EPS
$1.20-0.8%
$1.21
Rev
$440M+3.1%
$426M
Q1 2026
Feb 19, 2026
Metric
Actual
Est
EPS
$1.76+3.5%
$1.70
Rev
$472M+2.0%
$463M
Q4 2025
Oct 23, 2025
Metric
Actual
Est
EPS
$1.79+6.5%
$1.68
Rev
$468M+1.1%
$463M
Q3 2025
Jul 24, 2025
Metric
Actual
Est
EPS
$1.55-1.3%
$1.57
Rev
$476M+2.2%
$466M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$1.20vs $1.21-0.8%
$440Mvs $426M+3.1%
Q1 2026Feb 19, 2026
$1.76vs $1.70+3.5%
$472Mvs $463M+2.0%
Q4 2025Oct 23, 2025
$1.79vs $1.68+6.5%
$468Mvs $463M+1.1%
Q3 2025Jul 24, 2025
$1.55vs $1.57-1.3%
$476Mvs $466M+2.2%
Based on last 12 quarters of dataView full earnings history →

ITGR Peer Comparison

Integer Holdings Corporation (ITGR) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
LIVN logoLIVNLivaNova PLCDirect Competitor4.31B78.50-17.6410.74%7.47%9.13%0.39
ANIK logoANIKAnika Therapeutics, Inc.Direct Competitor193.24M14.42-18.97-5.91%-9.52%-7.74%0.17
LAKE logoLAKELakeland Industries, Inc.Direct Competitor99.48M10.08-3.8315.21%-10.88%-15.54%0.37
ATRC logoATRCAtriCure, Inc.Direct Competitor1.46B28.80-12014.88%-0.83%-0.95%0.18
ABT logoABTAbbott LaboratoriesProduct Competitor153.68B88.3811.574.59%31.88%27.26%0.32
MDT logoMDTMedtronic plcProduct Competitor101.86B79.3421.983.62%13%9.49%0.59
BSX logoBSXBoston Scientific CorporationProduct Competitor67.31B45.2923.3519.87%14.4%12.4%0.51

Compare ITGR vs Peers

Integer Holdings Corporation (ITGR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for ITGR.

Scale Benchmark

vs APH

Larger-name benchmark to compare ITGR against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, LIVN, ANIK, LAKE

ITGR Income Statement

Integer Holdings Corporation (ITGR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
1.14B1.22B1.26B1.07B1.22B1.33B1.56B1.72B1.85B1.85B
Revenue Growth %
5.63%6.95%3.55%-14.68%13.75%9.02%16.85%10.35%7.57%6.01%
Cost of Goods Sold
782.07M852.35M903.08M787.74M884.11M984.63M1.14B1.26B1.42B1.42B
COGS % of Revenue
68.84%70.15%71.78%73.38%72.4%73.96%73.55%73.13%76.94%-
Gross Profit
354.01M▲ 0%
362.67M▲ 2.4%
355.01M▼ 2.1%
285.71M▼ 19.5%
336.97M▲ 17.9%
346.65M▲ 2.9%
411.52M▲ 18.7%
461.18M▲ 12.1%
425.81M▼ 7.7%
431.27M▲ 0%
Gross Margin %
31.16%29.85%28.22%26.62%27.6%26.04%26.45%26.87%23.06%23.31%
Gross Profit Growth %
4.84%2.44%-2.11%-19.52%17.94%2.87%18.71%12.07%-7.67%-
Operating Expenses
228.36M207.11M197.38M165.09M201.26M233.97M248.2M252.95M216.54M238.69M
OpEx % of Revenue
20.1%17.05%15.69%15.38%16.48%17.58%15.95%14.74%11.73%-
Selling, General & Admin
143.07M142.45M138.88M137.21M141.69M157.36M171.47M184.33M162.59M176.93M
SG&A % of Revenue
12.59%11.72%11.04%12.78%11.6%11.82%11.02%10.74%8.81%-
Research & Development
48.85M48.6M46.53M48.47M51.98M59.76M61.97M53.42M46.35M51.54M
R&D % of Revenue
4.3%4%3.7%4.52%4.26%4.49%3.98%3.11%2.51%-
Other Operating Expenses
36.44M16.06M11.96M-20.58M7.58M16.85M14.76M15.2M7.6M3.13M
Operating Income
125.65M▲ 0%
155.56M▲ 23.8%
157.63M▲ 1.3%
120.61M▼ 23.5%
135.71M▲ 12.5%
112.68M▼ 17.0%
163.32M▲ 44.9%
208.24M▲ 27.5%
209.27M▲ 0.5%
192.57M▲ 0%
Operating Margin %
11.06%12.8%12.53%11.24%11.11%8.46%10.5%12.13%11.33%10.41%
Operating Income Growth %
35.22%23.8%1.34%-23.49%12.52%-16.97%44.95%27.5%0.49%-
EBITDA
206.83M237.09M235.53M199.94M217.3M203.57M260.31M317.95M335.22M328.42M
EBITDA Margin %
18.21%19.51%18.72%18.63%17.8%15.29%16.73%18.52%18.15%17.75%
EBITDA Growth %
24.75%14.63%-0.66%-15.11%8.69%-6.32%27.87%22.14%5.43%-1.84%
D&A (Non-Cash Add-back)
81.18M81.54M77.89M79.32M81.59M90.9M96.99M109.71M125.95M135.85M
EBIT
162.71M171.62M169.6M103.66M143.06M130.85M178.72M223.23M209.27M192.57M
Net Interest Income
-63.97M-99.31M-52.55M-38.22M-31.63M-37.27M-53.37M-56.37M-42.31M-37.98M
Interest Income
0000000000
Interest Expense
63.97M99.31M52.55M38.22M31.63M37.27M53.37M56.37M42.31M37.98M
Other Income/Expense
-76.39M-94.44M-52.44M-34.41M-34.65M-44M-57.94M-60.67M-83.87M-33.83M
Pretax Income
49.26M▲ 0%
61.12M▲ 24.1%
105.19M▲ 72.1%
86.21M▼ 18.0%
101.06M▲ 17.2%
68.68M▼ 32.0%
105.38M▲ 53.4%
147.56M▲ 40.0%
125.4M▼ 15.0%
158.75M▲ 0%
Pretax Margin %
4.34%5.03%8.36%8.03%8.28%5.16%6.77%8.6%6.79%8.58%
Income Tax
-37.83M14.08M13.97M8.95M8.04M8.93M16.24M26.51M22.57M16.95M
Effective Tax Rate %
-76.79%23.04%13.29%10.38%7.96%13%15.41%17.97%18%10.67%
Net Income
66.68M▲ 0%
167.96M▲ 151.9%
96.34M▼ 42.6%
77.26M▼ 19.8%
96.81M▲ 25.3%
66.38M▼ 31.4%
90.65M▲ 36.6%
119.9M▲ 32.3%
102.76M▼ 14.3%
141.8M▲ 0%
Net Margin %
5.87%13.82%7.66%7.2%7.93%4.99%5.83%6.98%5.57%7.67%
Net Income Growth %
1018.59%151.9%-42.64%-19.8%25.3%-31.43%36.57%32.26%-14.29%84.5%
Net Income (Continuing)
87.09M47.03M91.22M77.26M93.02M59.75M89.14M121.05M102.83M141.8M
Discontinued Operations
-20.41M120.93M5.12M03.79M6.63M1.51M-1.16M-68K0
Minority Interest
0000000000
EPS (Diluted)
2.08▲ 0%
5.15▲ 147.6%
2.77▼ 46.2%
2.33▼ 15.9%
2.80▲ 20.2%
1.96▼ 30.0%
2.69▲ 37.2%
3.40▲ 26.4%
2.89▼ 15.0%
4.12▲ 0%
EPS Growth %
994.74%147.6%-46.21%-15.88%20.17%-30%37.24%26.39%-15%90.05%
EPS (Basic)
2.125.232.802.352.821.972.723.602.96-
Diluted Shares Outstanding
32.06M32.6M33.04M33.11M33.26M33.36M33.76M35.65M35.59M34.43M
Basic Shares Outstanding
31.4M32.14M32.63M32.84M32.99M33.13M33.32M33.6M34.73M34.28M
Dividend Payout Ratio
----------

ITGR Balance Sheet

Integer Holdings Corporation (ITGR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
531.91M416.25M415.39M412.94M452.98M558.3M617.67M671.12M770.1M774.76M
Cash & Short-Term Investments
44.1M25.57M13.54M49.21M17.89M24.27M23.67M46.54M17.16M8.12M
Cash Only
44.1M25.57M13.54M49.21M17.89M24.27M23.67M46.54M17.16M8.12M
Short-Term Investments
0000000000
Accounts Receivable
194.84M185.5M216.75M198.51M251.79M298.25M317.15M349.04M346.08M327.78M
Days Sales Outstanding
62.655.7362.8867.575.2681.7774.4174.2268.4173.82
Inventory
176.74M190.08M167.26M149.32M155.7M208.77M229.1M247.13M253.74M284.48M
Days Inventory Outstanding
82.4981.467.669.1964.2877.3973.0971.8565.1968.71
Other Current Assets
106.75M000027M47.74M28.41M153.12M154.4M
Total Non-Current Assets
2.32B1.91B1.94B1.96B2.13B2.24B2.32B2.41B2.64B2.64B
Property, Plant & Equipment
370.38M231.27M288.56M299.12M347.15M400.9M501.41M579.57M671.97M675.31M
Fixed Asset Turnover
3.07x5.25x4.36x3.59x3.52x3.32x3.10x2.96x2.75x2.80x
Goodwill
990.24M832.34M839.62M859.44M924.7M982.19M1.01B1.02B1.11B1.11B
Intangible Assets
920.39M812.34M775.78M757.22M807.81M819.89M783.15M778.29M825.43M806.34M
Long-Term Investments
20.81M26.99M22.26M27.19M21.83M13.89M11.83M7.42M7.96M23.12M
Other Non-Current Assets
10.47M3.56M7.04M11.55M22.03M12.97M10.59M15.54M15.21M39.56M
Total Assets
2.85B▲ 0%
2.33B▼ 18.3%
2.35B▲ 1.1%
2.37B▲ 0.8%
2.58B▲ 8.9%
2.79B▲ 8.2%
2.94B▲ 5.3%
3.08B▲ 4.6%
3.41B▲ 10.8%
3.41B▲ 0%
Asset Turnover
0.40x0.52x0.53x0.45x0.47x0.48x0.53x0.56x0.54x0.54x
Asset Growth %
0.56%-18.31%1.14%0.8%8.87%8.22%5.31%4.6%10.81%29.33%
Total Current Liabilities
209M164.57M179.08M156.19M159.63M223.75M220.97M227.17M232.04M206.34M
Accounts Payable
64.55M57.19M64.97M51.57M76.86M110.78M118.26M101.5M113.13M115M
Days Payables Outstanding
30.1324.4926.2623.931.7341.0737.7329.5129.0729.35
Short-Term Debt
30.47M37.5M45.01M45.93M25.11M29.64M10.94M25.66M22.11M8.11M
Deferred Revenue (Current)
3.81M4.78M1.98M2.5M3.78M5.62M6.14M4.44M5.21M12.41M
Other Current Liabilities
64.68M10.23M17.04M10.63M7.1M17.91M16.3M20.88M22.87M83.23M
Current Ratio
2.54x2.53x2.32x2.64x2.84x2.50x2.80x2.95x3.32x3.75x
Quick Ratio
1.70x1.37x1.39x1.69x1.86x1.56x1.76x1.87x2.23x2.38x
Cash Conversion Cycle
114.96112.63104.22112.79107.81118.1109.77116.56104.54113.19
Total Non-Current Liabilities
1.75B1.1B1.02B944.61M1.07B1.15B1.2B1.23B1.43B1.51B
Long-Term Debt
1.58B888.01M777.27M693.76M812.88M907.07M959.92M980.15M1.27B1.37B
Capital Lease Obligations
0037.11M37.86M67.22M72.06M82.4M101.46M110.48M328.37M
Deferred Tax Liabilities
140.96M203.91M187.98M182.3M171.5M160.67M143.55M124.61M116.33M460.86M
Other Non-Current Liabilities
26.3M9.7M19.16M30.69M16.29M13.38M16.77M25.36M-61.99M20.04M
Total Liabilities
1.95B1.27B1.2B1.1B1.23B1.38B1.42B1.46B1.66B1.71B
Total Debt
1.61B925.51M859.39M777.55M905.81M1.01B1.05B1.1B1.4B1.38B
Net Debt
1.57B899.94M845.86M728.34M887.93M984.5M1.03B1.06B1.38B1.37B
Debt / Equity
1.80x0.87x0.75x0.61x0.67x0.71x0.69x0.68x0.80x0.81x
Debt / EBITDA
7.78x3.90x3.65x3.89x4.17x4.96x4.04x3.47x4.18x4.21x
Net Debt / EBITDA
7.60x3.80x3.59x3.64x4.09x4.84x3.95x3.32x4.12x4.18x
Interest Coverage
2.54x1.73x3.23x2.71x4.52x3.51x3.35x3.96x4.95x5.07x
Total Equity
893.38M▲ 0%
1.06B▲ 18.7%
1.15B▲ 8.7%
1.27B▲ 10.3%
1.35B▲ 6.6%
1.42B▲ 4.6%
1.52B▲ 7.2%
1.62B▲ 6.6%
1.75B▲ 7.9%
1.7B▲ 0%
Equity Growth %
23.18%18.71%8.67%10.29%6.58%4.63%7.17%6.59%7.87%30.8%
Book Value per Share
27.8732.5334.8838.3940.7342.4945.0045.4249.0749.28
Total Shareholders' Equity
893.38M1.06B1.15B1.27B1.35B1.42B1.52B1.62B1.75B1.7B
Common Stock
32K33K33K33K33K33K33K34K35K35K
Retained Earnings
176.07M344.5M440.26M517.52M614.32M680.7M771.35M891.25M994.05M1.01B
Treasury Stock
-4.65M-8.13M-8.81M00000-76.87M0
Accumulated OCI
52.18M33M19.99M52.69M27.19M5.33M20.22M-14.04M58.2M44.66M
Minority Interest
0000000000

ITGR Cash Flow Statement

Integer Holdings Corporation (ITGR) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
149.36M167.3M165.36M181.34M156.67M116.38M180.21M205.21M196.15M189.57M
Operating CF Margin %
13.15%13.77%13.14%16.89%12.83%8.74%11.58%11.95%10.62%-
Operating CF Growth %
41.53%12.01%-1.16%9.67%-13.61%-25.71%54.85%13.87%-4.41%-48.8%
Net Income
66.68M167.96M96.34M77.26M96.81M66.38M90.65M119.9M102.81M141.8M
Depreciation & Amortization
102.8M88.99M77.89M79.32M81.37M91.99M98.84M111.03M130.67M135.85M
Stock-Based Compensation
14.68M10.47M9.29M9.16M16.18M21.02M23.28M24.77M23.22M17.25M
Deferred Taxes
-59.21M61.13M-10.29M-6.97M-10.27M-17.5M-9.49M-14.11M-2.69M-6.72M
Other Non-Cash Items
20.99M-151.33M32.25M6.4M20.32M30.34M29.23M18.25M62.55M-18.55M
Working Capital Changes
3.43M-9.92M-40.13M16.16M-47.74M-75.85M-52.3M-54.62M-120.42M-80.05M
Change in Receivables
-34.6M9.29M-6.98M38.15M-17.54M-41.38M-21.08M-24.98M-89.66M-54.06M
Change in Inventory
-986K-16.09M3.72M18.44M4.7M-56.72M-30.18M-18.08M-2.58M-27.27M
Change in Payables
4.89M-94K1.89M-9.05M19.52M26.04M-520K-16.62M-566K-1.33M
Cash from Investing
-47.94M536.67M-58.86M-56.58M-271M-200.42M-163.37M-195.41M-270.73M-111.47M
Capital Expenditures
-47.3M-44.91M-48.2M-51.44M-53.46M-74.73M-119.94M00-27.48M
CapEx % of Revenue
4.16%3.7%3.83%4.79%4.38%5.61%7.71%6.15%4.93%1.49%
Acquisitions
472K581.43M-15.01M-5.22M-217.98M-126.64M-43.6M-138.54M-178.87M163.95M
Investments
----------
Other Investing
681K1.38M4.76M82K443K639K173K-56.87M-91.86M-233.94M
Cash from Financing
-111.67M-725.08M-117.93M-88.58M81.99M92.48M-18.01M13.32M43.56M-104.19M
Debt Issued (Net)
-128.56M-700.47M-117.89M-87.51M95.59M94.91M27.62M16.27M176.48M-58.89M
Equity Issued (Net)
19.32M12.41M-3.28M-3.82M-4.59M-2.93M-3.1M742K-46.37M-56.23M
Dividends Paid
0000000000
Share Repurchases
000-3.82M-4.59M-2.93M-3.1M0-50.01M-102.59M
Other Financing
-2.44M-37.02M3.24M2.75M-9.02M497K-42.54M-3.69M-86.55M10.94M
Net Change in Cash
-8.02M▲ 0%
-18.53M▼ 131.0%
-12.03M▲ 35.0%
35.67M▲ 396.4%
-31.32M▼ 187.8%
6.39M▲ 120.4%
-598K▼ 109.4%
22.87M▲ 3924.2%
-29.38M▼ 228.5%
-23.6M▲ 0%
Free Cash Flow
102.06M▲ 0%
122.39M▲ 19.9%
117.16M▼ 4.3%
129.9M▲ 10.9%
103.2M▼ 20.6%
41.65M▼ 59.6%
60.27M▲ 44.7%
99.6M▲ 65.2%
105.12M▲ 5.5%
167.97M▲ 0%
FCF Margin %
8.98%10.07%9.31%12.1%8.45%3.13%3.87%5.8%5.69%9.08%
FCF Growth %
117.6%19.93%-4.27%10.88%-20.55%-59.64%44.71%65.24%5.54%50.66%
FCF per Share
3.183.753.553.923.101.251.792.792.954.88
FCF Conversion (FCF/Net Income)
2.24x1.00x1.72x2.35x1.62x1.75x1.99x1.71x1.91x1.18x
Interest Paid
000024.74M35.8M37.7M54.17M00
Taxes Paid
000019.65M11.16M30.35M36.47M00

ITGR Key Ratios

Integer Holdings Corporation (ITGR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
8.24%17.19%8.71%6.38%7.37%4.79%6.17%7.64%6.11%8.23%
Return on Invested Capital (ROIC)
3.88%5.28%5.97%4.53%4.8%3.64%4.95%5.98%5.41%4.74%
Gross Margin
31.16%29.85%28.22%26.62%27.6%26.04%26.45%26.87%23.06%23.31%
Net Margin
5.87%13.82%7.66%7.2%7.93%4.99%5.83%6.98%5.57%7.67%
Debt / Equity
1.80x0.87x0.75x0.61x0.67x0.71x0.69x0.68x0.80x0.81x
Interest Coverage
2.54x1.73x3.23x2.71x4.52x3.51x3.35x3.96x4.95x5.07x
FCF Conversion
2.24x1.00x1.72x2.35x1.62x1.75x1.99x1.71x1.91x1.18x
Revenue Growth
5.63%6.95%3.55%-14.68%13.75%9.02%16.85%10.35%7.57%6.01%
Related:ITGR Dividend History·ITGR Revenue History·ITGR Price History·ITGR P/E History·ITGR Financial Ratios·ITGR Institutional Holders

ITGR SEC Filings & Documents

Integer Holdings Corporation (ITGR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 12, 2026·SEC

Material company update

Feb 19, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 23, 2026·SEC

FY 2025

Feb 20, 2025·SEC

FY 2024

Feb 20, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 23, 2025·SEC

FY 2025

Jul 24, 2025·SEC

ITGR Frequently Asked Questions

Integer Holdings Corporation (ITGR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Integer Holdings Corporation (ITGR) reported $1.85B in revenue for fiscal year 2025. This represents a 2235% increase from $79.2M in 1999.

Integer Holdings Corporation (ITGR) grew revenue by 7.6% over the past year. This is steady growth.

Yes, Integer Holdings Corporation (ITGR) is profitable, generating $141.8M in net income for fiscal year 2025 (5.6% net margin).

Dividend & Returns

Integer Holdings Corporation (ITGR) has a return on equity (ROE) of 6.1%. This is below average, suggesting room for improvement.

Integer Holdings Corporation (ITGR) generated $168.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ITGR back in 1999?

Total return calculator · dividends reinvested · 27+ years of data

See returns →

How much would $100/month in ITGR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →